Protective Effects of Citicoline and Benfotiamine Each Alone and in Combination on Streptozotocin-induced Memory Impairment in Mice
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: Diabetes mellitus is associated with cognitive disorders such as Alzheimer’s disease. Studies have shown that citicoline and benfotiamine can improve memory and learning through different mechanism of actions. The aim of this study was to compare the individual effects of benfotiamine (100, 200, 300 mg/kg) and citicoline (50, 100, 250, 500 mg/kg, gavage) and their co-administration on memory impairments in diabetic mice. Methods: Diabetes was induced by a single dose of streptozotocin (STZ, 140 mg/kg, intraperitoneal) and benfotiamine and/or citicoline were administered for three weeks. Memory was evaluated using the object recognition task (ORT) and passive avoidance test (PAT). Results: Results from ORT shows that citicoline at 50, 100, 250, and 500 mg/kg and benfotiamine at 100, 200, and 300 mg/kg and their combination (benfotiamine at 100 mg/kg added to citicoline at 50, 100, and 250 mg/kg) are equally effective in reversing the memory loss induced by STZ (p ＜ 0.001). PAT results demonstrate that citicoline at 100, 250, and 500 mg/kg and benfotiamine at above doses did not improve the latency time when administered separately, but benfotiamine at a fixed dose of 100 mg/kg in the presence of citicoline at 50, 100, and 250 mg/kg increased the latency time and improved memory significantly. Conclusion: In conclusion, in PAT, co-administration of benfotiamine and citicoline was more effective than either alone in improving memory. Regarding ORT, although benfotiamine added to citicoline improved memory notably, the difference between combination therapy and single-drug therapy was not considerable
Abstract
Objective: Diabetes mellitus is associated with cognitive disorders such as Alzheimer’s disease. Studies have shown that citicoline and benfotiamine can improve memory and learning through different mechanism of actions. The aim of this study was to compare the individual effects of benfotiamine (100, 200, 300 mg/kg) and citicoline (50, 100, 250, 500 mg/kg, gavage) and their co-administration on memory impairments in diabetic mice. Methods: Diabetes was induced by a single dose of streptozotocin (STZ, 140 mg/kg, intraperitoneal) and benfotiamine and/or citicoline were administered for three weeks. Memory was evaluated using the object recognition task (ORT) and passive avoidance test (PAT). Results: Results from ORT shows that citicoline at 50, 100, 250, and 500 mg/kg and benfotiamine at 100, 200, and 300 mg/kg and their combination (benfotiamine at 100 mg/kg added to citicoline at 50, 100, and 250 mg/kg) are equally effective in reversing the memory loss induced by STZ (p ＜ 0.001). PAT results demonstrate that citicoline at 100, 250, and 500 mg/kg and benfotiamine at above doses did not improve the latency time when administered separately, but benfotiamine at a fixed dose of 100 mg/kg in the presence of citicoline at 50, 100, and 250 mg/kg increased the latency time and improved memory significantly. Conclusion: In conclusion, in PAT, co-administration of benfotiamine and citicoline was more effective than either alone in improving memory. Regarding ORT, although benfotiamine added to citicoline improved memory notably, the difference between combination therapy and single-drug therapy was not considerable
참고문헌 (49)
- Gibson GE, "Abnormal thiamine-dependent processes in Alzheimer’s Disease. Lessons from diabetes", Mol Cell Neurosci, 55, pp.17~25 (2013)
- Scarpini E, "Treatment of Alzheimer’s disease : current status and new perspectives", Lancet Neurol, 2, pp.539~547 (2003)
- Schmitt B, "Combination therapy in Alzheimer’s disease : a review of current evidence", CNS Drugs, 18, pp.827~844 (2004)
- Conant R, "Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly : a review of the literature", Altern Med Rev, 9, pp.17~31 (2004)
- Abdel-Zaher AO, "Protective effect of citicoline against aluminum-induced cognitive impairments in rats", Toxicol Ind Health, 33, pp.308~317 (2017)
- Hoyumpa AM Jr, "Mechanisms of thiamin deficiency in chronic alcoholism", Am J Clin Nutr, 33, pp.2750~2761 (1980)
- Loew D, "Pharmacokinetics of thiamine derivatives especially of benfotiamine", Int J Clin Pharmacol Ther, 34, pp.47~50 (1996)
- Reggiani C, "Nervous tissue thiamine metabolism in vivo. I. Transport of thiamine and thiamine monophosphate from plasma to different brain regions of the rat", Brain Res, 293, pp.319~327 (1984)
- Reddy VP, "Oxidative stress in diabetes and Alzheimer’s disease", J Alzheimers Dis, 16, pp.763~774 (2009)
- Havivi E, "Vitamins and trace metals status in non insulin dependent diabetes mellitus", Int J Vitam Nutr Res, 61, pp.328~333 (1991)
- Gold M, "Plasma thiamine deficiency associated with Alzheimer’s disease but not Parkinson’s disease", Metab Brain Dis, 13, pp.43~53 (1998)
- Carvalho FM, "Thiamine deficiency decreases glutamate uptake in the prefrontal cortex and impairs spatial memory performance in a water maze test", Pharmacol Biochem Behav, 83, pp.481~489 (2006)
- Osiezagha K, "Thiamine deficiency and delirium", Innov Clin Neurosci, 10, pp.26~32 (2013)
- Gibson G, "The role of the cholinergic system in thiamin deficiency", Ann N Y Acad Sci, 378, pp.382~403 (1982)
- Rafii MS, "Recent developments in Alzheimer’s disease therapeutics", BMC Med, 7, pp.7~ (2009)
- Ke ZJ, "Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism", Neurochem Int, 45, pp.361~369 (2004)
- Matsushita S, "Elevated cerebrospinal fluid tau protein levels in Wernicke’s encephalopathy", Alcohol Clin Exp Res, 32, pp.1091~1095 (2008)
- Zhang Q, "Thiamine deficiency increases β-secretase activity and accumulation of β-amyloid peptides", Neurobiol Aging, 32, pp.42~53 (2011)
- Frank RA, "Structure, mechanism and catalytic duality of thiamine-dependent enzymes", Cell Mol Life Sci, 64, pp.892~905 (2007)
- Singh R, "Advanced glycation end-products : a review", Diabetologia, 44, pp.129~146 (2001)
- Shuvaev VV, "Increased protein glycation in cerebrospinal fluid of Alzheimer’s disease", Neurobiol Aging, 22, pp.397~402 (2001)
- La Selva M, "Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions", Diabetologia, 39, pp.1263~1268 (1996)
- Malekzadeh S, "Drugs induced Alzheimer’s disease in animal model", Galen Med J, 6, pp.185~196 (2017)
- Salkovic-Petrisic M, "What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research", J Neural Transm(Vienna), 120, pp.233~252 (2013)
- Zhang RS, "Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice", Neurobiol Learn Mem, 134(Pt B), pp.264~274 (2016)
- Das A, "Immobilization stress-induced changes in brain acetylcholinesterase activity and cognitive function in mice", Pharmacol Res, 42, pp.213~217 (2000)
- Todd KG, "Increased neuronal cell survival after L-deprenyl treatment in experimental thiamine deficiency", J Neurosci Res, 52, pp.240~246 (1998)
- Iga JI, "A case of Korsakoff’s syndrome improved by high doses of donepezil", Alcohol Alcohol, 36, pp.553~555 (2001)
- Zhong C, "Benfotiamine improves cognitive ability of Alzheimer’s patients independent of amyloid deposition", Alzheimer Dement, 12(7 Suppl), pp.P429~ (2016)
- Eleazu CO, "Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans", J Diabetes Metab Disord, 12, pp.60~ (2013)
- Goyal SN, "Challenges and issues with streptozotocin-induced diabetes-a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics", Chem Biol Interact, 244, pp.49~63 (2016)
- Furman BL, "Streptozotocin-induced diabetic models in mice and rats", Curr Protoc Pharmacol, 70, pp.5.47.1~5.47.20 (2015)
- D’Intino G, "Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats", Proc Natl Acad Sci U S A, 102, pp.3070~3075 (2005)
- Zugno AI, "Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia", Metab Brain Dis, 28, pp.501~508 (2013)
- Alvarez XA, "Citicoline improves memory performance in elderly subjects", Methods Find Exp Clin Pharmacol, 19, pp.201~210 (1997)
- Markova N, "Thiamine and benfotiamine improve memory, decrease depressive-like behavior and reduce brain expression of GSK3 beta in mice", 8th International Conference on Thiamine: from Catalysis to Pathology (2014)
- Pan X, "Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein", presenilin-1 transgenic mice, 2010, pp.133(Pt 5), 1342~1351
- Zweifler RM, "Membrane stabilizer : citicoline", Curr Med Res Opin, 18(Suppl 2), pp.s14~s17 (2002)
- Shen ZX, "Brain cholinesterases: II. The molecular and cellular basis of Alzheimer’s disease", Med Hypotheses, 63, pp.308~321 (2004)
- Cotroneo AM, "Effectiveness and safety of citicoline in mild vascular cognitive impairment : the IDEALE study", Clin Interv Aging, 8, pp.131~137 (2013)
- Fonlupt P, "Effect of CDP-choline on dopamine metabolism in central nervous system", International Meeting on Novel Biochemical, Pharmacological, and Clinical Aspects of Cytidinediphosphocholine (1984)
- Quillfeldt JA, "Rodent model as tools in ethical biomedical research", pp.271~311 (2016), Springer
- Cammarota M, "Retrieval and the extinction of memory", Cell Mol Neurobiol, 25, pp.465~474 (2005)
- Winters BD, "Object recognition memory : neurobiological mechanisms of encoding, consolidation and retrieval", Neurosci Biobehav Rev, 32, pp.1055~1070 (2008)
- Bizot JC, "Chronic treatment with sulbutiamine improves memory in an object recognition task and reduces some amnesic effects of dizocilpine in a spatial delayed-non-match-to-sample task", Prog Neuropsychopharmacol Biol Psychiatry, 29, pp.928~935 (2005)
- Hammond RS, "On the delay-dependent involvement of the hippocampus in object recognition memory", Neurobiol Learn Mem, 82, pp.26~34 (2004)
- Bermúdez-Rattoni F, "Insular cortex and amygdala lesions induced after aversive training impair retention : effects of degree of training", Neurobiol Learn Mem, 67, pp.57~63 (1997)
- Barker GR, "Recognition memory for objects, place, and temporal order : a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex", J Neurosci, 27, pp.2948~2957 (2007)
- Antunes M, "The novel object recognition memory : neurobiology, test procedure, and its modifications", Cogn Process, 13, pp.93~110 (2012)